BI
BIOGEN INC
BIIB· Health Care· BiotechnologyS&P 500
Close · 12/11/2026
250.48
1D
-1.15%52-week range
158.05 – 261
Volume
7,91,800.00
Price history
BIIB
14/10/2026 to 12/11/2026
O 255.00 H 255.05 L 250.43
1W+2.69%
1M+7.58%
3M+19.37%
6M+30.89%
1Y+56.98%
3Y+1.98%
5Y-10.67%
MAX-16.45%
Fundamentals
as of 12/11/2026- Market cap
- $37.03B
- Shares out
- 147.82M
- P/E (trailing)
- 106.55
- P/E (forward)
- 15.59
- EPS (trailing)
- 2.35
- Dividend yield
- 0.00%
- Beta
- 0.09
- Profit margin
- 3.37%
- P/B
- 1.96
- Return on equity
- 1.84%
SEC financial statements
68 quarterly and 19 annual periods through 30/09/2026.
Details
- Ticker
- BIIB
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
12 filers · 2 on watchlist · 15 buys · 9 sells · ?: 9 · D: 6 · R: 9
- 24/09/2026Maria Elvira SalazarSell+Biogen Inc. - Common Stock$1,001–$15,000
- 18/08/2026Kevin HernWSellBiogen Inc. - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyBiogen Inc. - Common Stock$1,001–$15,000
- 02/06/2026Maria Elvira SalazarSellBiogen Inc. - Common Stock$15,001–$50,000
- 05/06/2026Gilbert CisnerosBuyBiogen Inc. - Common Stock$1,001–$15,000
- 12/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$1,001–$15,000
- 11/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$1,001–$15,000
- 11/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$50,001–$100,000